CAS: 695207-56-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BC-LI-0186 REF: IN-DA01LNCBCAS: 695207-56-8 | 98% | To inquire | Mon 25 Nov 24 |
 | BC-LI-0186 REF: TM-T9533CAS: 695207-56-8 | 99.17% | 36.00 €~594.00 € | Mon 02 Dec 24 |
 | BC-LI-0186 REF: 3D-VCB20756CAS: 695207-56-8 | Min. 95% | To inquire | Tue 07 Jan 25 |
Ref: IN-DA01LNCB
| 5mg | 153.00 € | ||
| 10mg | 274.00 € | ||
| 25mg | 570.00 € | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 25 Nov 2024
BC-LI-0186
CAS:695207-56-8
BC-LI-0186 is a potent LRS-RagD inhibitor, IC50 of 46.11 nM, with selective RagD binding (Kd …
Formula:
C22H27N3O4S
Purity:
99.17%
Color and Shape:
Solid
Molecular weight:
429.53
Ref: TM-T9533
| 1mg | 36.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | 253.00 € | ||
| 50mg | 398.00 € | ||
| 100mg | 594.00 € | ||
| 1mL*10mM (DMSO) | 86.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
BC-LI-0186
CAS:695207-56-8
BC-LI-0186 is a synthetase inhibitor that has been shown to be an effective chemotherapeutic agent …
Formula:
C22H27N3O4S
Purity:
Min. 95%
Molecular weight:
429.5 g/mol
Ref: 3D-VCB20756
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
